CJC 1295 – 10MG

What Is CJC-1295? Benefits & Overview

CJC-1295 is a synthetic Growth Hormone Releasing Hormone (GHRH) analog and one of the most widely used GH-axis peptides available in Canada. By binding the GHRH receptor on pituitary somatotrophs, CJC-1295 amplifies GH synthesis and sustains baseline GH elevation — forming the foundation of the gold-standard CJC-1295 + Ipamorelin stack that combines GHRH and GHRP activity for synergistic GH pulse amplification.

This prolonged activity distinguishes CJC-1295 from unmodified GHRH analogs and makes it particularly valuable for chronic GH/IGF-1 axis studies, body composition research, and recovery biology models.

CJC-1295 Benefits & Uses

• Sustained GH and IGF-1 axis stimulation studies
• Lean body mass and muscle hypertrophy models
• Fat metabolism, lipolysis, and body composition research
• Sleep architecture and slow-wave sleep studies
• Recovery, repair, and anabolic hormone research
• Albumin-binding DAC pharmacokinetic studies

How CJC-1295 Works

CJC-1295 binds and activates the GHRH receptor (GHRHR) on pituitary somatotrophs, triggering the release of growth hormone in pulsatile fashion. The DAC modification reacts with endogenous albumin via a maleimide-thiol linkage, creating a depot that slowly releases active CJC-1295 over days. This results in elevated baseline GH and downstream IGF-1 production — key anabolic and lipolytic mediators in multiple tissue systems.

CJC-1295 10mg Vial Specifications

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3,647.1 Da
• Purity: ≥98% (third-party HPLC verified)
• Form: Lyophilized powder
• Vial Size: 10 mg
• Storage: −20 °C (long-term); 4 °C (short-term)
• Reconstitution: Bacteriostatic water

Why Buy CJC-1295 from Reviv Peptides

Reviv Peptides supplies CJC-1295 to licensed Canadian researchers with third-party verified purity, discreet shipping across Canada, and Certificates of Analysis available on request. Our sourcing and QC standards match those expected in a professional research environment.

CJC-1295 Canada FAQs

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC has a Drug Affinity Complex that binds albumin, extending its half-life to ~6–8 days. Without DAC (also called Modified GRF 1-29), the half-life is ~30 minutes, requiring more frequent administration in research protocols.

Is CJC-1295 often combined with Ipamorelin?

Yes. CJC-1295 stimulates GH release via the GHRH receptor, while Ipamorelin acts on the ghrelin receptor (GHSR). Their combined use produces a synergistic GH pulse — a common research combination. See our CJC-1295 + Ipamorelin Blend.

What purity is Reviv Peptides CJC-1295?

≥98% purity, confirmed by third-party HPLC. Certificate of Analysis available on request.

Reconstitution & Dosing Guide

How to Reconstitute

Add 3.0 mL of bacteriostatic water to the vial. Inject the water slowly down the inside wall of the vial — do not inject directly onto the powder. Gently swirl until fully dissolved; do not shake. This yields approximately 3.33 mg/mL. Store the reconstituted vial at 4 °C and use within 28 days.

Low Starting Dose

• Dose per injection: 100 mcg — 3 units (0.03 mL) on a U-100 insulin syringe
• Frequency: Once daily, subcutaneous injection (at bedtime)
• Cycle length: 8–12 weeks

Titrate to 250–300 mcg by weeks 7–12 as tolerated.

Start at the lowest effective dose and adjust based on individual response. Consult a qualified healthcare professional before use.